| Literature DB >> 32396580 |
Vladimir Mashanov1,2, Jennifer Akiona1, Maleana Khoury1, Jacob Ferrier3, Robert Reid3, Denis Jacob Machado3, Olga Zueva1, Daniel Janies3.
Abstract
Cell signaling pathways play key roles in coordinating cellular events in development. The Notch signaling pathway is highly conserved across all multicellular animals and is known to coordinate a multitude of diverse cellular events, including proliferation, differentiation, fate specification, and cell death. Specific functions of the pathway are, however, highly context-dependent and are not well characterized in post-traumatic regeneration. Here, we use a small-molecule inhibitor of the pathway (DAPT) to demonstrate that Notch signaling is required for proper arm regeneration in the brittle star Ophioderma brevispina, a highly regenerative member of the phylum Echinodermata. We also employ a transcriptome-wide gene expression analysis (RNA-seq) to characterize the downstream genes controlled by the Notch pathway in the brittle star regeneration. We demonstrate that arm regeneration involves an extensive cross-talk between the Notch pathway and other cell signaling pathways. In the regrowing arm, Notch regulates the composition of the extracellular matrix, cell migration, proliferation, and apoptosis, as well as components of the innate immune response. We also show for the first time that Notch signaling regulates the activity of several transposable elements. Our data also suggests that one of the possible mechanisms through which Notch sustains its activity in the regenerating tissues is via suppression of Neuralized1.Entities:
Year: 2020 PMID: 32396580 PMCID: PMC7217437 DOI: 10.1371/journal.pone.0232981
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of DAPT (3 μM) treatment on the structure of the regenerating arm (day 14 post-autotomy).
A—A ′″: Aboral view of regenerating arms from four representative control animals exposed to DMSO (vehicle). Two arms from each animal are shown. B—B′″: Aboral view of regenerating arms from four representative animals exposed to 3 μM DAPT. Two arms from each animal are shown. C and D: Representative sagittal sections through the regenerating arm of a control (DMSO-treated) individual (C) and a DAPT-treated individual (D). Hematoxylin and eosin staining. Arrowheads show the arm outgrowth (regenerate). Dashed lines show the position of the autotomy plane. Abbreviations: ac—arm coelom; rnc—radial nerve cord; rvc—radial canal of the water-vascular system.
Fig 2Boxplots showing the effect of DAPT (3 μM) treatment on the length of the outgrowth (A) and the number of segments in the regenerating arm (B). By day 14 post-autotomy, the DAPT treatment significantly reduced both the total length of the outgrowth (by the factor of 1.6, T-test p-value = 0.002) and the number of segments in the new arm (by the factor of 1.4, T-test p-value = 0.047).
Key metrics of the de novo assembly.
| Metric | Value |
|---|---|
| Total assembled bases | 1,038,536,368 nt |
| Number of contigs | 2,463,269 |
| Number of Trinity “genes” | 1,169,021 |
| Shortest contig | 151 nt |
| Longest contig | 48,146 nt |
| Average contig length | 421.6 nt |
| Median contig length | 260 nt |
| Contig N50 | 527 nt |
| Overall read alignment rate | 94.09% |
| Reads aligned as proper pairs | 75.42% |
| Full-length transcript representation | 7,397 (out of 35,786) |
| Complete (single-copy/duplicated) BUSCOs | 98.7% (28.8%/69.9%) |
Fig 3Differentially expressed genes in the DAPT-treated animals as compared to the control (DMSO-treated) cohort.
Volcano plot showing the log2 fold change on the X-axis and -log10 of adjusted p-values on the Y-axis. The significantly up-regulated transcripts (red) are to the right, and significantly down-regulated transcripts (blue) are to the left. Each gene is represented with a dot. Grey dots represent the genes whose expression level did not change significantly in response to DAPT treatment. The differentially expressed contigs were defined as those whose associated adjusted p-value was less than 0.05 and the log2 fold change in expression exceeded ±0.58. Volcano plot showing the log2 fold change on the X-axis and -log10 of adjusted p-values on the Y-axis. Each gene is represented with a dot. The 1,978 significantly up-regulated transcripts (red) are to the right, and the 2,434 significantly down-regulated transcripts (blue) are to the left. Grey dots represent the genes whose expression level did not change significantly in response to DAPT treatment. The differentially expressed contigs were defined as those whose associated adjusted p-value was less than 0.05 and the log2 fold change in expression exceeded ±0.58.). Boxed labels represent UniProt IDs (with label copy number within parenthesis) shown in Tables 2 and 3.
DAVID functional clustering of down-regulated genes.
| Annotation Cluster | Representative Annotation Term | Enrichment score | Representative Ortholog | UniprotID | Log2 Fold Change |
|---|---|---|---|---|---|
| 1 | GO:0005578∼proteinaceous extracellular matrix | 1.27 | Tenascin-X | P22105 | -6.33 |
| 2 | GO:0009628∼response to abiotic stimulus | 1.24 | Receptor-type tyrosine-protein phosphatase kappa | Q15262 | -6.25 |
| 3 | GO:0005576∼extracellular region | 1.00 | Cartilage intermediate layer protein 1 | O75339 | -2.65 |
| 4 | GO:0004842∼ubiquitin-protein transferase activity | 1.00 | E3 ubiquitin-protein ligase TRIM56 | Q80VI1 | -3.34 |
| 5 | GO:0006955∼immune response | 0.90 | Mannan-binding lectin serine protease 1 | P98064 | -5.36 |
| 6 | GO:1902287∼semaphorin-plexin signaling pathway involved in axon guidance | 0.67 | Plexin-B | Q9V4A7 | -7.44 |
| 7 | GO:0007166∼cell surface receptor signaling pathway | 0.53 | Kremen protein 2 | Q8K1S7 | -5.53 |
| 8 | GO:0007010∼cytoskeleton organization | 0.27 | Abnormal spindle-like microcephaly-associated protein homolog | P62288 | -6.16 |
| 9 | GO:0016567∼protein ubiquitination | 0.24 | TNF receptor-associated factor 6 | B6CJY4 | -5.68 |
| 10 | GO:0005783∼endoplasmic reticulum | 0.20 | Retinol dehydrogenase 11 | Q9QYF1 | -2.03 |
| 11 | GO:0006873∼cellular ion homeostasis | 0.19 | Sodium-driven chloride bicarbonate exchanger | Q32LP4 | -1.24 |
| 12 | GO:0009653∼anatomical structure morphogenesis | 0.18 | Tyrosine-protein kinase receptor Tie-2 | O73791 | -7.24 |
| 13 | GO:0006468∼protein phosphorylation | 0.14 | Macrophage-stimulating protein receptor | Q04912 | -7.27 |
| 14 | GO:0005840∼ribosome | 0.11 | 40S ribosomal protein S11 | P41115 | -6.12 |
| 15 | GO:0051641∼cellular localization | 0.08 | Endophilin-A1 | Q8AXV1 | -3.93 |
| 16 | GO:1901265∼nucleoside phosphate binding | 0.05 | dCTP pyrophosphatase 1 | Q32KY6 | -4.74 |
| 17 | GO:0012505∼endomembrane system | 0.02 | Calsyntenin-1 | O94985 | -5.7 |
| 18 | GO:0044237∼cellular metabolic process | 0.01 | 26S proteasome non-ATPase regulatory subunit 11 | F6XBL2 | -1.73 |
DAVID functional clustering of up-regulated genes.
| Annotation Cluster | Representative Annotation Term | Enrichment score | Representative Ortholog | UniprotID | Log2 Fold Change |
|---|---|---|---|---|---|
| 1 | GO:0002376∼immune system process | 1.49 | Deleted in malignant brain tumors 1 protein | Q9UGM3 | 2.19 |
| 2 | GO:0002682∼regulation of immune system process | 1.18 | TNF receptor-associated factor 3 | Q13114 | 1.76 |
| 3 | GO:0010941∼regulation of cell death | 1.08 | Cell death specification protein 2 | Q94126 | 1.78 |
| 4 | PF13445:RING-type zinc-finger | 0.84 | Tripartite motif-containing protein 2 | Q9ESN6 | 1.83 |
| 5 | GO:0080134∼regulation of response to stress | 0.77 | Heat shock factor-binding protein 1 | O75506 | 4.29 |
| 6 | GO:0007154∼cell communication | 0.74 | Mitogen-activated protein kinase 12 Map3k12 | 60700 | v6.03 |
| 7 | GO:0048856∼anatomical structure development | 0.71 | Myeloid differentiation primary response protein MyD88 | Q5XJ85 | 2.73 |
| 8 | GO:0004842∼ubiquitin-protein transferase activity | 0.69 | Kelch-like protein 24 | Q56A24 | 1.04 |
| 9 | GO:0004871∼signal transducer activity | 0.68 | Gamma-aminobutyric acid type B receptor subunit 1 | H2L0Q3 | 1.53 |
| 10 | GO:0005576∼extracellular region | 0.65 | Kielin/chordin-like protein | Q9IBG7 | 6.05 |
| 11 | GO:0006163∼purine nucleotide metabolic process | 0.64 | 2’-5’-oligoadenylate synthase 1A | P11928 | 5.61 |
| 12 | GO:0080134∼regulation of response to stress | 0.61 | Hypoxia up-regulated protein 1 | Q9Y4L1 | 7.17 |
| 13 | PF00431:CUB domain | 0.58 | Kremen protein 1 | Q90Y90 | 1.82 |
| 14 | GO:0016021∼integral component of membrane | 0.46 | Tumor necrosis factor receptor superfamily member EDAR | Q90VY2 | 3.32 |
| 15 | GO:0007010∼cytoskeleton organization | 0.45 | Dynactin subunit 1 | P35458 | 1.92 |
| 16 | GO:0045944∼positive regulation of transcription from RNA polymerase II promoter | 0.40 | ETS domain-containing protein Elk-1 | P19419 | 1.37 |
| 17 | GO:0017076∼purine nucleotide binding | 0.32 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Q9Y3Z3 | 1.06 |
| 18 | GO:0071944∼cell periphery | 0.29 | Transmembrane cell adhesion receptor mua-3 | P34576 | 7.91 |
| 19 | GO:0044430∼cytoskeletal part | 0.21 | Protein Skeletor | Q9VGY6 | 6.80 |
| 20 | GO:0051246∼regulation of protein metabolic process | 0.21 | NAD-dependent protein deacetylase sirtuin-2 | Q7ZVK3 | 5.17 |
| 21 | GO:0006468∼protein phosphorylation | 0.19 | Alpha-protein kinase vwkA | Q6B9X6 | 4.09 |
| 22 | GO:0032991∼macro-molecular complex | 0.17 | Splicing factor 3B subunit 1 | O57683 | 6.15 |
| 23 | GO:0044281∼small molecule metabolic process | 0.14 | Elongation of very long chain fatty acids protein 4 | Q3S8M | 2.00 |
| 24 | GO:0044085∼cellular component biogenesis | 0.09 | Breast carcinoma-amplified sequence 3 | Q9H6U6 | 2.89 |
| 25 | GO:0005783∼endoplasmic reticulum | 0.08 | Receptor expression-enhancing protein 2 | Q8VCD6 | 1.08 |
| 26 | GO:0005739∼mitochondrion | 0.07 | Cytochrome b-c1 complex subunit 2, mitochondrial | Q9DB77 | 5.31 |
| 27 | GO:0003723∼RNA binding | 0.05 | Chromobox protein homolog 7 | P60889 | 2.65 |
Down-regulated genes, unmapped by DAVID.
| Trinity Transcript | Blast Hit Uniprot ID | Gene Name | Representative Annotation Term | Log2 Fold Change |
|---|---|---|---|---|
| TRINITY_DN113732_c3_g1_i1 | P21328 | RNA-directed DNA polymerase from mobile element jockey | GO:0003964∼RNA-directed DNA polymerase activity | -2.46 |
| TRINITY_DN87639_c0_g1_i2 | Q8I7P9 | Retrovirus-related Pol polyprotein from transposon opus | GO:0003964∼RNA-directed DNA polymerase activity, GO:0015074∼DNA integration | -5.67 |
| TRINITY_DN127189_c0_g1_i17 | Q10126 | Putative uncharacterized transposon-derived protein F52C9.6 | NA | -2.75 |
| TRINITY_DN154220_c1_g1_i9 | Q95SX7 | Probable RNA-directed DNA polymerase from transposon BS | GO:0003964∼RNA-directed DNA polymerase | -2.09 |
| TRINITY_DN82736_c0_g1_i1 | P14381 | Transposon TX1 uncharacterized 149 kDa protein | NA | -5.95 |
| TRINITY_DN168317_c0_g1_i3 | P08548 | LINE-1 reverse transcriptase homolog | GO:0003964∼RNA-directed DNA polymerase activity | -2.60 |
| TRINITY_DN164170_c2_g2_i1 | P10394 | Retrovirus-related Pol polyprotein from transposon 412 | GO:0003964∼RNA-directed DNA polymerase activity, GO:0015074∼DNA integration | -3.85 |
| TRINITY_DN138975_c0_g1_i8 | Q9PVW8 | Rhamnose-binding lectin | GO:0030246∼carbohydrate binding | -3.96 |
| TRINITY_DN159770_c4_g1_i1 | P06027 | Echinoidin | GO:0030246∼carbohydrate binding | -4.95 |
| TRINITY_DN100482_c2_g1_i8 | A8V0B3 | Neuromacin | GO:0006952∼defense response | -5.04 |
| TRINITY_DN141895_c2_g1_i5 | Q9U8W7 | Techylectin-5B | GO:0030246∼carbohydrate binding, GO:0098609∼cell-cell adhesion | -3.16 |
| TRINITY_DN111423_c2_g1_i4 | P38505 | Calcium-binding protein | GO:0005509∼calcium ion binding | -3.70 |
| TRINITY_DN150199_c1_g2_i1 | Q2YEM9 | Tripartite motif-containing protein 5 | GO:0051607∼defense response to virus, GO:0006914∼autophagy | -4.42 |
Up-regulated genes, unmapped by DAVID.
| Trinity Transcript | Blast Hit Uniprot ID | Gene Name | Representative Annotation Term | Log2 Fold Change |
|---|---|---|---|---|
| TRINITY_DN113902_c12_g1-_i20 | P34257 | Transposable element Tc3 transposase | GO:0006313∼transposition, DNA-mediated | 3.95 |
| TRINITY_DN96178_c0_g1_i1 | P04323 | Retrovirus-related Pol polyprotein from transposon 17.6 | GO:0003964∼RNA-directed DNA polymerase activity | 2.84 |
| TRINITY_DN155494_c1_g1_i1 | Q9NBX4 | Probable RNA-directed DNA polymerase from transposon X-element | GO:0003964∼RNA-directed DNA polymerase activity | 5.33 |
| TRINITY_DN147574_c9_g2_i2 | Q95SX7 | Probable RNA-directed DNA polymerase from transposon BS | GO:0003964∼RNA-directed DNA polymerase | 6.69 |
| TRINITY_DN116575_c4_g1_i14 | O50655 | Integrase/recombinase xerD homolog | GO:0044826∼viral genome integration into host DNA | 4.46 |
| TRINITY_DN163877_c0_g2_i2 | Q09575 | Uncharacterized protein K02A2.6 | GO:0015074∼DNA integration | 2.80 |
| TRINITY_DN91925_c0_g1_i1 | P46023 | G-protein coupled receptor GRL101 | GO:0007186∼G protein-coupled receptor signaling pathway | 3.49 |
| TRINITY_DN93460_c0_g1_i14 | Q9I926 | Fucolectin-6 | GO:0045088∼regulation of innate immune response | 5.33 |
| TRINITY_DN89036_c0_g1_i1 | F7J220 | Scavenger receptor cysteine-rich domain superfamily protein | GO:0045087∼innate immune response | 2.60 |
| TRINITY_DN163643_c0_g1_i11 | Q53B88 | Nucleotide-binding oligomerization domain-containing protein 2 | GO:0045087∼innate immune response | 4.20 |
| TRINITY_DN87261_c0_g1_i1 | Q9GV77 | Extracellular matrix protein 3 | GO:0007155∼cell adhesion | 7.73 |
| TRINITY_DN136305_c0_g1_i9 | P81721 | Vesicular acetylcholine transporter | GO:0006836∼neurotrans-mitter transport | 3.28 |
| TRINITY_DN160426_c0_g1_i8 | Q9U518 | L-asparaginase | GO:0006520∼cellular amino acid metabolic process | 2.17 |
| TRINITY_DN111554_c1_g1_i4 | A7X3X8 | C-type lectin lectoxin-Enh5 | GO:0030246∼carbohydrate binding | 6.7 |
| TRINITY_DN88709_c0_g1_i1 | Q01414 | Transcriptional regulator ERG homolog | GO:0003700∼DNA-binding transcription factor activity | 5.90 |
| TRINITY_DN105897_c0_g3_i1 | Q8TQD0 | Macrodomain-containing protein MA_1614 | NA | 5.62 |
| TRINITY_DN91758_c0_g1_i1 | C0HL13 | Low-density lipoprotein receptor-related protein 2 | GO:0006898∼receptor-mediated endocytosis | 5.20 |